VSE Capital Markets

Board Meeting

As on : 27 Jan 2020

BSE Code	Company	Date	Purpose
500010	H D F C	27-Jan-2020	HOUSING DEVELOPMENT FINANCE CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve the unaudited financial results of Housing Development Finance Corporation Limited ('the Corporation') for the quarter/nine months ending December 31, 2019 and closure of trading window.
500052	Bhansali Engg.	27-Jan-2020	BHANSALI ENGINEERING POLYMERS LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2019. Further to our letter having ref. no. BEPL/SEC/2019/137 dated 30th December, 2019, we wish to inform you that the trading window for dealing in the Company''s Equity shares by the designated persons and/or their immediate relatives was already closed w.e.f. 1st January, 2020 and that the same shall open on 30th January, 2020. Kindly take above information on record.
500124	Dr Reddy's Labs	27-Jan-2020	DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve Board Meeting scheduled on Monday, January 27, 2020, inter alia, for Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2019 Intimation regarding closure of trading window Newspaper publication for Board meeting (As Per BSE Announcement Dated 27.12.2019)
500179	HCL Infosystems	27-Jan-2020	HCL INFOSYSTEMS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) (a) of SEBI (LODR) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of HCL Infosystems Limited is scheduled to be held on Monday, 27th January, 2020 at Noida (U.P.) inter-alia to consider and take on record the unaudited Financial Results of the Company on standalone and consolidated basis for the quarter ended 31st December, 2019. We further wish to inform you that the Trading Window in respect of dealing in the Shares of the Company have been closed from 1st January, 2020 to 29th January, 2020 (both days inclusive) for the Directors, Promoters, Designated Persons and the Connected Persons as per the Company's Insider Trading code adopted under SEBI (Prohibition of Insider Trading) Regulations, 2015 and SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018. Further, please be informed that the investor conference call will be held on Tuesday, 28th January, 2020 at 04:00 PM IST.
500252	Lak. Mach. Works	27-Jan-2020	LAKSHMI MACHINE WORKS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter/Nine Months ended 31st December, 2019. The Company announces the trading window closure period from wednesday the 01st January, 2020 to wednesday, the 29th January, 2020 (both days inclusive). In terms of Regulations-46 & 47 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that the Notice of Board Meeting to be held on Monday, the 27th January, 2020 is published today in Dinamalar (Tamil) and Business Line(English) and the copy is enclosed herewith. The same is being posted in the Company''s website.
500420	Torrent Pharma.	27-Jan-2020	TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve 1. A meeting of the Board of Directors will be held on Monday, 27-Jan-20, inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-19. 2. In the above meeting, the Board would also consider the following: i. Payment oflnterim Dividend for the year 2019-20. ii. . Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares is approved by the Board of Directors, Shareholders''approval will be taken through postal ballot. TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve 1. A meeting of the Board of Directors will be held on Monday, 27-Jan-20, inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-19. 2. In the above meeting, the Board would also consider the following: i. Payment oflnterim Dividend for the year 2019-20. ii. . Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares is approved by the Board of Directors, Shareholders''approval will be taken through postal ballot. 1. A meeting of the Board of Directors will be held on Monday, 27-Jan-20, inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-19. 2. In the above meeting, the Board would also consider the following: i. Payment oflnterim Dividend for the year 2019-20. ii. . Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares is approved by the Board of Directors, Shareholders''approval will be taken through postal ballot. Torrent Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on January 27, 2020, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on December 31, 2019 (Q3). In the above meeting, the Board would also consider the following: 1. Payment of lnterim Dividend for the year 2019-20. 2. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares is approved by the Board of Directors, Shareholders' approval will be taken through postal ballot. Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Tuesday,04th February, 2020 as the Record Date for taking record of the Members of the Company for the purpose of payment of Interim Dividend, if declared by the Board at their meeting scheduled to be held on Monday, 27th January, 2020.
501111	Gold Rock Inves.	27-Jan-2020	GOLD ROCK INVESTMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve To consider, approve & take on record the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2020 and limited review report of the auditor for the period ended December 31, 2020. To consider appointment of Shri Ketan Sethi Company Secretary and Compliance Officer w.e.f January 27, 2020 GOLD ROCK INVESTMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve 1. To consider, approve & take on record the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2019 and limited review report of the auditor for the period ended December 31, 2019.2. To consider appointment of Shri Ketan Sethi Company Secretary and Compliance Officer w.e.f January 27, 2020
502281	Triveni Glass	27-Jan-2020	TRIVENI GLASS LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve Approval of the Financial Results for the quarter ended 31.12.2019 and other matters. BM notice published in newspaper as per attachment. (As Per BSE Announcement Dated 21.01.2020)
502420	Orient Paper	27-Jan-2020	ORIENT PAPER & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Monday, the 27th January,2020 to consider inter alia Unaudited Quarterly Financial Results of the Company for the quarter ended 31st December, 2019 subject to 'Limited Review' by the Auditors of the Company.
503162	Rel. Chemotex	27-Jan-2020	RELIANCE CHEMOTEX INDUSTRIES LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve 1. To Consider the Un-Audited Financial Result for the quarter ended on 31st December, 2019. 2. Any other Agenda with the permission of chair.

< 12 3 4 5 6 >

3rd Floor,Fortune Tower,Sayajigunj, Vadodara 390020, Gujarat, India

Telephone: +91 265 2361534

Customer Care Number: +91 265 2361474

Customer Care Timings: Monday to Friday 8:30am to 6:15pm

Email Address: vse@vselindia.com / compliance@vselindia.com

Attention Investors:

"Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
KYC is one time exercise while dealing in securities market - once KYC is done through a SEBI registered intermediary (broker , DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

For any complaints pertaining to securities broking please write to compliance@vselindia.com, for DP related to dp@vselindia.com. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed.